Interventional Treatment of Cardiac Emergencies in Children with Congenital Heart Diseases

Open access

Abstract

Cardiac emergencies in children represent an extremely important issue in medical practice. In general, interventional treatment could be optional in many situations, however it can be indicated in emergency conditions. There are many diseases at pediatric age that can benefit from interventional treatment, thus reducing the surgical risks and subsequent complications. Balloon atrioseptostomy, patent ductus arteriosus (PDA) closure, percutaneous or hybrid closure of a ventricular septal defect, pulmonary or aortic valvuloplasty, balloon angioplasty for aortic coarctation, implantation of a stent for coarctation of the aorta, for severe stenosis of the infundibulum of the right ventricle, or for PDA correction are among the procedures that can be performed in emergency situations. This review aims to present the current state of the art in the field of pediatric interventional cardiology.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Feltes TF Bacha E Beekman RH 3rd et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2607-2652. doi: 10.1161/CIR.0b013e31821b1f10.

  • 2. Cinteza E Balgradean M Filip C et al. Iodinated Contrast Media in Pediatric Cardiac Angiography Nephrotoxic Risk Evaluation. REVISTA DE CHIMIE. 2018;69:511-514.

  • 3. Balgradean M Cinteza E Filipoiu F et al. Gentamicin infections and acute tubular necrosis in children. FARMACIA. 2013;61:772-780.

  • 4. Chessa M Carminati M Cinteza E et al. Partial anomalous drainage of superior and inferior caval veins into the left atrium and other cardiac associated anomalies: two case reports. Rom J Morphol Embryol. 2016;2:559-562.

  • 5. Cinteza E Carminati M. Balloon atrial septostomy – almost half a century after. Maedica. 2013;8:280-284.

  • 6. Kitano M Tsukada M Fujino M. Wire Atrial Septostomy. World J Pediatr Congenit Heart Surg. 2017:2150135116686929. doi: 10.1177/2150135116686929.

  • 7. Celiker A Bilgiç A Alehan D Ozkutlu S Ozer S. Blade atrial septostomy: experience with 18 patients. Turk J Pediatr. 1996;38:459-466.

  • 8. Kumar N Shaikh AS Kumari V Patel N. Echocardiography guided bed side balloon atrial septostomy in dextro transposed great arteries (dTGA) with intact ventricular septum (IVS): A resource limited country experience. Pak J Med Sci. 2018;34:1347-1352. doi: 10.12669/pjms.346.15792.

  • 9. O'Byrne ML Glatz AC Song L et al. Association Between Variation in Preoperative Care Before Arterial Switch Operation and Outcomes in Patients With Transposition of the Great Arteries. Circulation. 2018;138:2119-2129. doi: 10.1161/CIRCULATIONAHA.118.036145.

  • 10. Polito A Ricci Z Fragasso T Cogo PE. Balloon atrial septostomy and pre-operative brain injury in neonates with transposition of the great arteries: a systematic review and a meta-analysis. Cardiol Young. 2012;22:1-7. doi: 10.1017/S1047951111001909.

  • 11. Anderson BR Ciarleglio AJ Hayes DA Quaegebeur JM Vincent JA Bacha EA. Earlier arterial switch operation improves outcomes and reduces costs for neonates with transposition of the great arteries. J Am Coll Cardiol. 2014;63:481-487. doi: 10.1016/j.jacc.2013.08.1645.

  • 12. Melekoglu AN Baspinar O. Transcatheter cardiac interventions in neonates with congenital heart disease: A single centre experience. J Int Med Res. 2018:300060518806111. doi: 10.1177/0300060518806111.

  • 13. Yan C Niu G Niu H Li L Wan L Li H. Stable Interatrial Communication Combining Balloon Atrial Septostomy and Radiofrequency Catheter Ablation. J Am Coll Cardiol. 2018;72:1873-1875. doi: 10.1016/j.jacc.2018.07.058.

  • 14. Savorgnan F Zaban NB Elhoff JJ Ross MM Breinholt JP. No difference found in safety or efficacy of balloon atrial septostomy performed at the bedside versus the catheterisation laboratory. Cardiol Young. 2018;28:1421-1425. doi: 10.1017/S1047951118001439.

  • 15. Holzer RJ. Pulmonary valvuloplasty. In Complications during percutaneous interventions for congenital and structural heart disease. Eds: Hijazi Z Feldman T Cheatham JP Sievert H. Informa Healthcare; 2009 p. 62-67.

  • 16. Loureiro P Cardoso B Gomes IB Martins JF Pinto FF. Long-term results of percutaneous balloon valvuloplasty in neonatal critical pulmonary valve stenosis: a 20-year single-centre experience. Cardiol Young. 2017;27:1314-1322. doi: 10.1017/S1047951117000178.

  • 17. Yucel IK Bulut MO Kucuk M Balli S Celebi A. Intervention in Patients with Critical Pulmonary Stenosis in the Ductal Stenting Era. Pediatr Cardiol. 2016:37:1037-1045. doi: 10.1007/s00246-016-1386-7.

  • 18. Ronai C Ghelani SJ Marshall AC et al. Characterization of Left Ventricular Dysfunction by Myocardial Strain in Critical Pulmonary Stenosis and Pulmonary Atresia After Neonatal Pulmonary Valve Balloon Dilation. Am J Cardiol. 2018;pii:S0002-9149(18)32040-X. doi: 10.1016/j.amjcard.2018.10.025.

  • 19. Fedderly RT Lloyd TR Mendelsohn AM Beekman RH. Determinants of successful balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum. J Am Coll Cardiol. 1995;25:460-465.

  • 20. Santoro G Formigari R Carlo DD Pasquini L Ballerini L. Midterm outcome after pulmonary balloon valvuloplasty in patients younger than one year of age. Am J Cardiol. 1995;75:637-639.

  • 21. Tynan M Jones O Joseph MC Deverall PB Yates AK. Relief of pulmonary valve stenosis in first week of life by percutaneous ballon valvuloplasty. Lancet. 1984;1:273.

  • 22. Holzer RJ Gauvreau K Kreutzer J et al. Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv. 2012;80:663-672. doi: 10.1002/ccd.23473.

  • 23. Garty Y Veldtman G Lee K Benson L. Late outcomes after pulmonary valve balloon dilatation in neonates infants and children. The Journal of Invasive Cardiology. 2005;17:318-322.

  • 24. McCrindle BW. Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Am J Cardiol. 1996;77:286-293.

  • 25. Javois AJ. Aortic Valvuloplasty Complications. In Complications during percutaneous interventions for congenital and structural heart disease. Eds: Hijazi Z Feldman T Cheatham JP Sievert H. Informa Healthcare; 2009 p. 9-86.

  • 26. Prijic SM Vukomanovic VA Stajevic MS et al. Balloon dilation and surgical valvotomy comparison in non-critical congenital aortic valve stenosis. Pediatr Cardiol. 2015;36:616-624. doi: 10.1007/s00246-014-1056-6.

  • 27. Balmer C Beghetti M Fasnacht M Friedli B Arbenz U. Balloon aortic valvoplasty in paediatric patients: progressive aortic regurgitation is common. Heart. 2004;90:77-81.

  • 28. Borghi A Agnoletti G Valsecchi O Carminati M. Aortic balloon dilatation for congenital aortic stenosis: report of 90 cases (1986-98). Heart. 1999:82:e10.

  • 29. Brown DW Dipilato AE Chong EC Lock JE McElhinney DB. Aortic valve reinterventions after balloon aortic valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol. 2010:56:1740-1749. doi: 10.1016/j.jacc.2010.06.040.

  • 30. Brown JW Rodefeld MD Ruzmetov M Eltayeb O Yurdakok O Turrentine MW. Surgical valvuloplasty versus balloon aortic dilation for congenital aortic stenosis: are evidence-based outcomes relevant? Ann Thorac Surg. 2012:94:146-155. doi: 10.1016/j.athoracsur.2012.02.054.

  • 31. Ewert P Bertram H Breuer J et al. Balloon valvuloplasty in the treatment of congenital aortic valve stenosis – A retrospective multicenter survey of more than 1000 patients. Int J Cardiol. 2011:149:182-185. doi: 10.1016/j.ijcard.2010.01.005.

  • 32. Pedra CA Sidhu R McCrindle BW et al. Outcomes after balloon dilation of congenital aortic stenosis in children and adolescents. Cardiol Young. 2004:14:315-321. doi: 10.1017/S1047951104003105.

  • 33. Filho RIR Manica JLL. Aortic Coarctation. In Cardiac Catheterization for Congenital Heart Disease. From Fetal Life to Adulthood. Springer-Verlag Italia. Eds: Butera G Chessa M Eicken A Thomson J; 2015 p. 335-353.

  • 34. Cinteza EE Filip Cristina Bogdan Andrada Nicolescu A Mahmoud Hyam. Atretic aortic coarctation – transradial approach. Case series and review of the literature. Rom J Morphol Embryol. 2017;58:1029-1033.

  • 35. Salcher M Naci H Law TJ Kuehne T Schubert S Kelm M. Cardioproof Consortium. Balloon Dilatation and Stenting for Aortic Coarctation: A Systematic Review and Meta-Analysis. Circ Cardiovasc Interv. 2016;pii:e003153. doi: 10.1161/CIRCINTERVENTIONS.115.003153.

  • 36. Fernandes JF Goubergrits L Brüning J et al. Beyond Pressure Gradients: The Effects of Intervention on Heart Power in Aortic Coarctation. PLoS One. 2017;12:e0168487. doi: 10.1371/journal.pone.0168487.

  • 37. Nguyen L Cook SC. Coarctation of the Aorta: Strategies for Improving Outcomes. Cardiol Clin. 2015;33:521-530. doi: 10.1016/j.ccl.2015.07.011.

  • 38. Chen SS Dimopoulos K Alonso-Gonzalez R et al. Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair. Int J Cardiol. 2014;173:209-215. doi: 10.1016/j.ijcard.2014.02.012.

  • 39. Luijendijk P Bouma BJ Groenink M et al. Surgical versus percutaneous treatment of aortic coarctation: new standards in an era of transcatheter repair. Expert Rev Cardiovasc Ther. 2012;10:1517-1531. doi: 10.1586/erc.12.158.

  • 40. Rao PS Galal O Smith PA Wilson AD. Five- to nine-year follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol. 1996;27:462-470.

  • 41. Rao PS Jureidini SB Balfour IC Singh GK Chen SC. Severe aortic coarctation in infants less than 3 months: successful palliation by balloon angioplasty. J Invasive Cardiol. 2003;15:202-208.

  • 42. Qureshi SA Rosenthal E Tynan M. Should balloon angioplasty be used instead of surgery for native aortic coarctation? Heart. 1997;77:86-87.

  • 43. Sivakumar K. PDA stenting in Duct-Dependent Pulmonary Circulation. In Cardiac Catheterization for Congenital Heart Disease. From Fetal Life to Adulthood. Springer-Verlag Italia. Eds: Butera G Chessa M Eicken A Thomson J; 2015 p. 375-399.

  • 44. Quandt D Ramchandani B Penford G et al. Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot. Heart. 2017;103:1985-1991. doi: 10.1136/heartjnl-2016-310620.

  • 45. Quandt D Ramchandani B Stickley J et al. Stenting of the Right Ventricular Outflow Tract Promotes Better Pulmonary Arterial Growth Compared With Modified Blalock-Taussig Shunt Palliation in Tetralogy of Fallot-Type Lesions. JACC Cardiovasc Interv. 2017;10:1774-1784.

  • 46. Bigdelian H Ghaderian M Sedighi M. Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt. Indian Heart J. 2018;70Suppl3:S394-S398. doi: 10.1016/j.ihj.2018.06.020.

  • 47. Cools B Boshoff D Heying R Rega F Meyns B Gewillig M. Transventricular balloon dilation and stenting of the RVOT in small infants with tetralogy of Fallot with pulmonary atresia. Catheter Cardiovasc Interv. 2013;82:260-265. doi: 10.1002/ccd.24548.

  • 48. Kang SL Benson L. Recent advances in cardiac catheterization for congenital heart disease. F1000Res. 2018;7:370. doi: 10.12688/f1000research.13021.1.

  • 49. Sandoval JP Chaturvedi RR Benson L et al. Right Ventricular Outflow Tract Stenting in Tetralogy of Fallot Infants With Risk Factors for Early Primary Repair. Circ Cardiovasc Interv. 2016;9pii:e003979. doi: 10.1161/CIRCINTERVENTIONS.116.003979.

  • 50. Stumper O Ramchandani B Noonan P et al. Stenting of the right ventricular outflow tract. Heart. 2013;99:1603-1608. doi: 10.1136/heartjnl-2013-304155.

  • 51. Kanter KR Kogon BE Kirshbom PM et al. Symptomatic neonatal tetralogy of Fallot: repair or shunt? Ann Thorac Surg. 2010;89:858-863. doi: 10.1016/j.athoracsur.2009.12.060.

  • 52. Zampi JD Armstrong AK Hirsch-Romano JC. Hybrid perventricular pulmonary valve perforation and right ventricular outflow stent placement: a case report of a premature 1.3-kg neonate with tetralogy of Fallot and pulmonary atresia. World J Pediatr Congenit Heart Surg. 2014;5:338-341. doi: 10.1177/2150135113512136.

  • 53. Barron DJ Ramchandani B Murala J et al. Surgery following primary right ventricular outflow tract stenting for Fallot's tetralogy and variants: rehabilitation of small pulmonary arteries. Eur J Cardiothorac Surg. 2013;44:656-662. doi: 10.1093/ejcts/ezt188.

  • 54. Ahmad Z Alwi M. Pulmonary Atresia and Intact Ventricular Septum. In Cardiac Catheterization for Congenital Heart Disease. From Fetal Life to Adulthood. Springer-Verlag Italia. Eds: Butera G Chessa M Eicken A Thomson J; 2015 p. 279-297.

  • 55. Holzer RJ Cheatham JP. Radiofrequency perforation of the pulmonary valve in patients with pulmonary atresia and intact ventricular septum. In Complications during percutaneous interventions for congenital and structural heart disease. Eds: Hijazi Z Feldman T Cheatham JP Sievert H. Informa Healthcare; 2009 p. 68-72.

  • 56. Santoro G Capozzi G Capogrosso C et al. Pulmonary artery growth after arterial duct stenting in completely duct-dependent pulmonary circulation. Heart. 2016;102:459-464. doi: 10.1136/heartjnl-2015-308493.

  • 57. Bentham JR Zava NK Harrison WJ et al. Duct Stenting Versus Modified Blalock-Taussig Shunt in Neonates With Duct-Dependent Pulmonary Blood Flow: Associations With Clinical Outcomes in a Multicenter National Study. Circulation. 2018;137:581-588. doi: 10.1161/CIRCULATIONAHA.117.028972.

  • 58. McMullan DM Permut LC Jones TK et al. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. J Thorac Cardiovasc Surg. 2014;147:397-401. doi: 10.1016/j.jtcvs.2013.07.052.

  • 59. Mallula K Vaughn G El-Said H et al. Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum. Catheter Cardiovasc Interv. 2015;85:1196-1202. doi: 10.1002/ccd.25870.

  • 60. Santoro G Gaio G Capozzi G et al. Fate of Hypoplastic Pulmonary Arteries After Arterial Duct Stenting in Congenital Heart Disease With Duct-Dependent Pulmonary Circulation. JACC Cardiovasc Interv. 2015;8:1626-1632. doi: 10.1016/j.jcin.2015.05.027.

  • 61. Sivakumar K Bhagyavathy A Coelho R et al. Longevity of neonatal ductal stenting for congenital heart diseases with duct-dependent pulmonary circulation. Congenit Heart Dis. 2012;7:526-533. doi: 10.1111/j.1747-0803.2012.00657.x.

  • 62. Amoozgar H Cheriki S Borzoee M et al. Short-term result of ductus arteriosus stent implantation compared with surgically created shunts. Pediatr Cardiol. 2012;33:1288-1294.

  • 63. Lee K Seto W Benson L et al. Pharmacokinetics of sirolimus-eluting stents implanted in the neonatal arterial duct. Circ Cardiovasc Interv. 2015;pii:e002233.

  • 64. Cinteza E Ungureanu A Balgradean M et al. Beneficial Effects of Acetaminophen on the Chemical Mediators Involved in the Closure of Patent Ductus Arteriosus. REVISTA DE CHIMIE. 2018;69:1537-1540.

  • 65. Holzer RJ Cheatham JP. Occlusion of the patent arterial duct. In Complications during percutaneous interventions for congenital and structural heart disease. Eds: Hijazi Z Feldman T Cheatham JP Sievert H. Informa Healthcare; 2009 p. 185-191.

  • 66. Backes CH Rivera BK Bridge JA et al. Percutaneous Patent Ductus Arteriosus (PDA) Closure During Infancy: A Meta-analysis. Pediatrics. 2017;pii:e20162927. doi: 10.1542/peds.2016-2927.

  • 67. Backes CH Cheatham SL Deyo GM et al. Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications. J Am Heart Assoc. 2016;pii:e002923. doi: 10.1161/JAHA.115.002923.

  • 68. Abadir S Boudjemline Y Rey C et al. Significant persistent ductus arteriosus in infants less or equal to 6 kg: percutaneous closure or surgery? Arch Cardiovasc Dis. 2009;102:533-540. doi: 10.1016/j.acvd.2009.04.004.

  • 69. Baspinar O Sahin DA Sulu A et al. Transcatheter closure of patent ductus arteriosus in under 6 kg and premature infants. J Interv Cardiol. 2015;28:180-189. doi: 10.1111/joic.12196.

  • 70. Dimas VV Takao C Ing FF et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤ 6 kg. JACC Cardiovasc Interv. 2010;3:1295-1299. doi: 10.1016/j.jcin.2010.08.022.

  • 71. Backes CH Kennedy KF Locke M et al. Transcatheter Occlusion of the Patent Ductus Arteriosus in 747 Infants <6 kg: Insights From the NCDR IMPACT Registry. JACC Cardiovasc Interv. 2017;10:1729-1737. doi: 10.1016/j.jcin.2017.05.018.

  • 72. Zahn EM Nevin P Simmons C et al. A novel technique for transcatheter patent ductus arteriosus closure in extremely preterm infants using commercially available technology. Catheter Cardiovasc Interv. 2015;85:240-248. doi: 10.1002/ccd.25534.

  • 73. Bentham J Meur S Hudsmith L et al. Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv. 2011;77:409-15. doi: 10.1002/ccd.22637.

  • 74. Zahn EM Peck D Phillips A et al. Transcatheter Closure of Patent Ductus Arteriosus in Extremely Premature Newborns: Early Results and Midterm Follow-Up. JACC Cardiovasc Interv. 2016;9:2429-2437. doi: 10.1016/j.jcin.2016.09.019.

  • 75. Baruteau AE Hascoët S Baruteau J et al. Transcatheter closure of patent ductus arteriosus: past present and future. Arch Cardiovasc Dis. 2014;107:122-132. doi: 10.1016/j.acvd.2014.01.008.

  • 76. Cinteza EE Butera G. Complex ventricular septal defects. Update on percutaneous closure. Rom J Morphol Embryol. 2016;57:1195-1205.

  • 77. Amin Z Gu X Berry JM Titus JL Gidding SS Rocchini AP. Perventricular closure of ventricular septal defects without cardiopulmonary bypass. Ann Thorac Surg. 1999;68:149-154.

  • 78. Michel-Behnke I Ewert P Koch A et al. Device closure of VSD by hybrid procedures. Catheter Cardiovasc Interv. 2011;77:242-51.

  • 79. Velasco-Sanchez D Tzikas A Ibrahim R Miró J. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2. Catheter Cardiovasc Interv. 2013;82:474-479. doi: 10.1002/ccd.25004.

  • 80. Mallula K Patel N Amin Z. New design of the Amplatzer membranous VSD occluder: a step forward? Pediatr Cardiol. 2013;34:2068-2072. doi: 10.1007/s00246-013-0636-1.

  • 81. Walsh MA Bialwoski J Szkutnik M et al. Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects. Heart. 2006;92:1295-1297. doi: 10.1136/hrt.2005.084988.

  • 82. Yang J Yang L Yu S et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-1168. doi: 10.1016/j.jacc.2014.01.008.

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 145 145 31
PDF Downloads 176 176 33